FDA inspection
BioChroma Analytical Labs, LLC.: FDA inspection ending Feb 23, 2026
FDA inspection 1305488 · No Action Indicated (NAI) · Dallas, TX
Key facts
| Inspection ID | 1305488 |
|---|---|
| Firm | BioChroma Analytical Labs, LLC. |
| FEI number | 3012816120 |
| Address | 1309 Record Crossing Rd |
| City | Dallas |
| State | TX |
| ZIP | 75235 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Feb 23, 2026 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data